Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

SM04755 may be an effective topical treatment for psoriasis.

A new compound shows promise as a topical treatment for hair loss.

The herbal cream effectively smooths and straightens hair safely.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

The herbal cream effectively smooths and straightens hair safely.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

GI197111X is best dissolved in Capmul MCM for trials.

BMS-470539 reduces skin fibrosis and inflammation.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Five FDA-approved drugs may help block COVID-19 virus entry.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.